Stocks and Investing
Stocks and Investing
Wed, March 14, 2018
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Tue, March 13, 2018
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Mon, March 12, 2018
Oren Livnat Initiated (CARA) at Strong Buy and Held Target at $22 on, Mar 12th, 2018
Oren Livnat of HC Wainwright & Co., Initiated "Cara Therapeutics, Inc." (CARA) at Strong Buy and Held Target at $22 on, Mar 12th, 2018.
Oren has made no other calls on CARA in the last 4 months.
There are 2 other peers that have a rating on CARA. Out of the 2 peers that are also analyzing CARA, 0 agree with Oren's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Oren
- Ken Trbovich of "Janney Montgomery Scott" Upgraded from Hold to Strong Buy on, Monday, February 12th, 2018
- Corey Davis of "Seaport Global" Initiated at Strong Buy and Held Target at $27 on, Friday, January 19th, 2018